4
Changes in Ownership
GENELUX Corp Filed Acc 0001415889-25-012806
VP, Pharmaceutical Development sold 4,737 shares at $2.92 ($13,832)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cappello Joseph VP, Pharmaceutical Development | 2025-05-12 | Sale | −4,737 | $2.92 | $13,832 | 52,266 | D |
| Open-market sales · 4,737 sh · avg $2.92 · $13,832 | |||||||
Loading xslF345X05/form4-05132025_050531.xml…